Abstract
Purpose
Identification of the molecular subtypes in breast cancer allows to optimize treatment strategies, but usually requires invasive needle biopsy. Recently, non-invasive imaging has emerged as promising means to classify them. Magnetic resonance imaging is often used for this purpose because it is three-dimensional and highly informative. Instead, only a few reports have documented the use of mammograms. Given that mammography is the first choice for breast cancer screening, using it to classify molecular subtypes would allow for early intervention on a much wider scale. Here, we aimed to evaluate the effectiveness of combining global and local mammographic features by using Vision Transformer (ViT) and Convolutional Neural Network (CNN) to classify molecular subtypes in breast cancer.
Methods
The feature values for binary classification were calculated using the ViT and EfficientnetV2 feature extractors, followed by dimensional compression via principal component analysis. LightGBM was used to perform binary classification of each molecular subtype: triple-negative, HER2-enriched, luminal A, and luminal B.
Results
The combination of ViT and CNN achieved higher accuracy than ViT or CNN alone. The sensitivity for triple-negative subtypes was very high (0.900, with F-value = 0.818); whereas F-value and sensitivity were 0.720 and 0.750 for HER2-enriched, 0.765 and 0.867 for luminal A, and 0.614 and 0.711 for luminal B subtypes, respectively.
Conclusion
Features obtained from mammograms by combining ViT and CNN allow the classification of molecular subtypes with high accuracy. This approach could streamline early treatment workflows and triage, especially for poor prognosis subtypes such as triple-negative breast cancer.
Similar content being viewed by others
Data availability
The datasets analyzed during the current study are available in The Chinese Mammography Database (CMMD) repository, The Cancer Imaging Archive (https://doi.org/https://doi.org/10.7937/tcia.eqde-4b16).
Abbreviations
- AI:
-
Artificial intelligence
- CC:
-
Craniocaudal
- CNN:
-
Convolutional neural network
- CMMD:
-
Chinese mammography database
- CESM:
-
Contrast-enhanced spectral mammography
- MLO:
-
Mediolateral oblique
- MRI:
-
Magnetic resonance imaging
- PCA:
-
Principal component analysis
- ViT:
-
Vision transformer
References
Curigliano G, Burstein HJ, Gnant M, Loibl S, Cameron D, Regan MM et al (2023) Understanding breast cancer complexity to improve patient outcomes: the st gallen international consensus conference for the primary therapy of individuals with early breast cancer 2023. Ann Oncol 34:970–986. https://doi.org/10.1016/j.annonc.2023.08.017
Amoroso N, Pomarico D, Fanizzi A, Didonna V, Giotta F, La Forgia D et al (2021) A roadmap towards breast cancer therapies supported by explainable artificial intelligence. Appl Sci 11:4881. https://doi.org/10.3390/app11114881
Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA et al (2000) Molecular portraits of human breast tumours. Nature 406:747–752. https://doi.org/10.1038/35021093
Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout RGPM, Granton P et al (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48:441–446. https://doi.org/10.1016/j.ejca.2011.11.036
Demircioglu A, Grueneisen J, Ingenwerth M, Hoffmann O, Pinker-Domenig K, Morris E et al (2020) A rapid volume of interest-based approach of radiomics analysis of breast MRI for tumor decoding and phenotyping of breast cancer. PLoS ONE 15:e0234871. https://doi.org/10.1371/journal.pone.0234871
Fan M, Liu Z, Xu M, Wang S, Zeng T, Gao X, Li L (2020) Generative adversarial network-based super-resolution of diffusion-weighted imaging: application to tumour radiomics in breast cancer. NMR Biomed 33:e4345. https://doi.org/10.1002/nbm.4345
Leithner D, Mayerhoefer ME, Martinez DF, Jochelson MS, Morris EA, Thakur SB, Pinker K (2020) Non-invasive assessment of breast cancer molecular subtypes with multiparametric magnetic resonance imaging radiomics. J Clin Med 9:1853. https://doi.org/10.3390/jcm9061853
Ma M, Gan L, Jiang Y, Qin N, Li C, Zhang Y, Wang X (2021) Radiomics analysis based on automatic image segmentation of DCE-MRI for predicting triple-negative and nontriple-negative breast cancer. Comput Math Methods Med 2021:2140465. https://doi.org/10.1155/2021/2140465
Yue WY, Zhang HT, Gao S, Li G, Sun ZY, Tang Z et al (2023) Predicting breast cancer subtypes using magnetic resonance imaging based radiomics with automatic segmentation. J Comput Assist Tomogr 47:729–737. https://doi.org/10.1097/RCT.0000000000001474
Huang G, Du S, Gao S, Guo L, Zhao R, Bian X et al (2024) Molecular subtypes of breast cancer identified by dynamically enhanced MRI radiomics: the delayed phase cannot be ignored. Insights Imag 15:127. https://doi.org/10.1186/s13244-024-01713-9
Ha R, Mutasa S, Karcich J, Gupta N, Pascual Van Sant E, Nemer J et al (2019) Predicting breast cancer molecular subtype with MRI dataset utilizing convolutional neural network algorithm. J Digit Imaging 32:276–282. https://doi.org/10.1007/s10278-019-00179-2
Sun R, Meng Z, Hou X, Chen Y, Yang Y, Huang G, Nie S (2021) Prediction of breast cancer molecular subtypes using DCE-MRI based on CNNs combined with ensemble learning. Phys Med Biol. https://doi.org/10.1088/1361-6560/ac195a
Zhang Y, Chen JH, Lin Y, Chan S, Zhou J, Chow D et al (2021) Prediction of breast cancer molecular subtypes on DCE-MRI using convolutional neural network with transfer learning between two centers. Eur Radiol 31:2559–2567. https://doi.org/10.1007/s00330-020-07274-x
Li W, Wang S, Xie W, Feng C (2023) A quantitative heterogeneity analysis approach to molecular subtype recognition of breast cancer in dynamic contrast-enhanced magnetic imaging images from radiomics data. Quant Imaging Med Surg 13:4429–4446. https://doi.org/10.21037/qims-22-1230
Xie X, Zhou H, Ma M, Nie J, Gao W, Zhong J et al (2024) A deep learning model for predicting molecular subtype of breast cancer by fusing multiple sequences of DCE-MRI from two institutes. Acad Radiol. https://doi.org/10.1016/j.acra.2024.03.002
Petrillo A, Fusco R, Barretta ML, Granata V, Mattace Raso M, Porto A et al (2023) Radiomics and artificial intelligence analysis by T2-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging to predict breast cancer histological outcome. Radiol Med 128:1347–1371. https://doi.org/10.1007/s11547-023-01718-2
Gu J, Jiang T (2022) Ultrasound radiomics in personalized breast management: current status and future prospects. Front Oncol 12:963612. https://doi.org/10.3389/fonc.2022.963612
Jiang M, Zhang D, Tang SC, Luo XM, Chuan ZR, Lv WZ et al (2021) Deep learning with convolutional neural network in the assessment of breast cancer molecular subtypes based on US images: a multicenter retrospective study. Eur Radiol 31:3673–3682. https://doi.org/10.1007/s00330-020-07544-8
La Forgia D, Fanizzi A, Campobasso F, Bellotti R, Didonna V, Lorusso V et al (2020) Radiomic analysis in contrast-enhanced spectral mammography for predicting breast cancer histological outcome. Diagnostics (Basel) 10:708. https://doi.org/10.3390/diagnostics10090708
Petrillo A, Fusco R, Di Bernardo E, Petrosino T, Barretta ML, Porto A et al (2022) Prediction of breast cancer histological outcome by radiomics and artificial intelligence analysis in contrast-enhanced mammography. Cancers (Basel) 14:2132. https://doi.org/10.3390/cancers14092132
Ma W, Zhao Y, Ji Y, Guo X, Jian X, Liu P, Wu S (2019) Breast cancer molecular subtype prediction by mammographic radiomic features. Acad Radiol 26:196–201. https://doi.org/10.1016/j.acra.2018.01.023
Ueda D, Yamamoto A, Takashima T, Onoda N, Noda S, Kashiwagi S et al (2021) Training, validation, and test of deep learning models for classification of receptor expressions in breast cancers from mammograms. JCO Precis Oncol 5:543–551. https://doi.org/10.1200/PO.20.00176
Litjens G, Kooi T, Bejnordi BE, Setio AAA, Ciompi F, Ghafoorian M et al (2017) A survey on deep learning in medical image analysis. Med Image Anal 42:60–88. https://doi.org/10.1016/j.media.2017.07.005
Dosovitskiy A, Beyer L, Kolesnikov A, Weissenborn D, Zhai X, Unterthiner T, et al An image is worth 16x16 words: Transformers for image recognition at scale. arXiv:2010.11929
Ali H, Mohsen F, Shah Z (2023) Improving diagnosis and prognosis of lung cancer using vision transformers: a scoping review. BMC Med Imaging 23:129. https://doi.org/10.1186/s12880-023-01098-z
Gheflati B, Rivaz H. Vision transformers for classification of breast ultrasound images (2022) Annu Int Conf IEEE Eng Med Biol Soc 480–483. https://doi.org/10.1109/EMBC48229.2022.9871809.
Chen X, Zhang K, Abdoli N, Gilley PW, Wang X, Liu H et al (2022) Transformers improve breast cancer diagnosis from unregistered multi-view mammograms. Diagnostics (Basel) 12:1549. https://doi.org/10.3390/diagnostics12071549
Lian J, Deng J, Hui ES, Koohi-Moghadam M, She Y, Chen C et al (2022) Early stage NSCLS patients’ prognostic prediction with multi-information using transformer and graph neural network model. Elife 11:e80547. https://doi.org/10.7554/eLife.80547
Ayana G, Dese K, Dereje Y, Kebede Y, Barki H, Amdissa D et al (2023) Vision-transformer-based transfer learning for mammogram classification. Diagnostics (Basel) 13:178. https://doi.org/10.3390/diagnostics13020178
Fanizzi A, Fadda F, Comes MC, Bove S, Catino A, Di Benedetto E et al (2023) Comparison between vision transformers and convolutional neural networks to predict non-small lung cancer recurrence. Sci Rep 13:20605. https://doi.org/10.1038/s41598-023-48004-9
Qu X, Lu H, Tang W, Wang S, Zheng D, Hou Y, Jiang J (2022) A VGG attention vision transformer network for benign and malignant classification of breast ultrasound images. Med Phys 49:5787–5798. https://doi.org/10.1002/mp.15852
Tagnamas J, Ramadan H, Yahyaouy A, Tairi H (2024) Multi-task approach based on combined CNN-transformer for efficient segmentation and classification of breast tumors in ultrasound images. Vis Comput Ind Biomed Art 7:2. https://doi.org/10.1186/s42492-024-00155-w [published correction appears in Vis Comput Ind Biomed Art 2024 7:5. https://doi.org/10.1186/s42492-024-00156-910.1186/s42492-024-00156-9]
Xiong Y, Du B, Xu Y, Deng J, She Y, Chen C (2022) Pulmonary nodule classification with multi-view convolutional Vision Transformer. Int Joint Conference Neural Networks (IJCNN) 2022:1–7. https://doi.org/10.1109/IJCNN55064.2022.9892716
Cui C, Li L, Cai H, Fan Z, Zhang L, Dan T et al (2021) The chinese mammography database (CMMD): an online mammography database with biopsy confirmed types for machine diagnosis of breast. Cancer Imaging Arch. https://doi.org/10.7937/tcia.eqde-4b16
Cai H, Wang J, Dan T, Li J, Fan Z, Yi W et al (2023) An online mammography database with biopsy confirmed types. Sci Data 10:123. https://doi.org/10.1038/s41597-023-02025-1
https://huggingface.co/timm/tf_efficientnetv2_m.in21k_ft_in1k
Mingxing Tan, Quoc v. Le EfficientNetV2: Smaller models and faster training. arXiv:2104.00298
Akiba T, Sano S, Yanase T, Ohta T, Koyama M (2019) Optuna: A next-generation hyperparameter optimization framework. https://doi.org/10.1145/3292500.3330701, arXiv:1907.10902
American College of Radiology (2013) Breast Imaging Reporting and Data System: BI-RADS atlas, 5th edn. American College of Radiology, Reston
Ko ES, Lee BH, Kim HA, Noh WC, Kim MS, Lee SA (2010) Triple-negative breast cancer: correlation between imaging and pathological findings. Eur Radiol 20:1111–1117. https://doi.org/10.1007/s00330-009-1656-3
Tamaki K, Ishida T, Miyashita M, Amari M, Ohuchi N, Tamaki N, Sasano H (2011) Correlation between mammographic findings and corresponding histopathology: potential predictors for biological characteristics of breast diseases. Cancer Sci 102:2179–2185. https://doi.org/10.1111/j.1349-7006.2011.02088.x
Evans AJ, Pinder SE, James JJ, Ellis IO, Cornford E (2006) Is mammographic spiculation an independent, good prognostic factor in screening-detected invasive breast cancer? AJR Am J Roentgenol 187:1377–1380. https://doi.org/10.2214/AJR.05.0725
Wang Y, Ikeda DM, Narasimhan B, Longacre TA, Bleicher RJ, Pal S et al (2008) Estrogen receptor-negative invasive breast cancer: Imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression. Radiology 246:367–375. https://doi.org/10.1148/radiol.2462070169
Gastounioti A, Desai S, Ahluwalia VS, Conant EF, Kontos D (2022) Artificial intelligence in mammographic phenotyping of breast cancer risk: a narrative review. Breast Cancer Res 24:14. https://doi.org/10.1186/s13058-022-01509-z
Li C, Lu N, He Z, Tan Y, Liu Y, Chen Y et al (2022) A noninvasive tool based on magnetic resonance imaging radiomics for the preoperative prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer. Ann Surg Oncol 29:7685–7693. https://doi.org/10.1245/s10434-022-12034-w
Cheng Y, Xu S, Wang H, Wang X, Niu S, Luo Y, Zhao N (2022) Intra- and peri-tumoral radiomics for predicting the sentinel lymph node metastasis in breast cancer based on preoperative mammography and MRI. Front Oncol 12:1047572. https://doi.org/10.3389/fonc.2022.1047572
Acknowledgements
We would like to thank Yuta Hirono from Niigata University of Health and Welfare for useful discussions. We would like to thank Editage (www.editage.jp) for English language editing. This work was supported by the JSPS Grant-in-Aid for Scientific Research (C) (Grant Number JP23K10899).
Funding
This work was supported by the JSPS Grant-in-Aid for Scientific Research (C) (Grant Number JP23K10899).
Author information
Authors and Affiliations
Contributions
All authors contributed to the conception and design of the study. Chiharu Kai, Hideaki Tamori, and Satoshi Kasai performed formal analyses. All authors have read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing Interests
Chiharu Kai and Satoshi Kasai were employed and received salaries from KONICA MINOLTA, INC. Satoshi Kasai received a research grant and consulting fee and has stocks from KONICA MINOLTA, INC. Tsunehiro Ohtsuka received research funding from KONICA MINOLTA, INC. Hideaki Tamori is affiliated with The Asahi Shimbun Company. Hitoshi Futamura is affiliated with KONICA MINOLTA, INC. The remaining authors declare that this study was conducted in the absence of commercial or financial relationships that could be construed as potential conflicts of interest.
Ethical approval
This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by The Institutional Review Board of Niigata University of Health and Welfare (Approval No. 19313–240613).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kai, C., Tamori, H., Ohtsuka, T. et al. Classifying the molecular subtype of breast cancer using vision transformer and convolutional neural network features. Breast Cancer Res Treat (2025). https://doi.org/10.1007/s10549-025-07614-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10549-025-07614-9